FDA inspection
Fresenius Kabi USA LLC: FDA inspection ending Feb 18, 2026
FDA inspection 1311592 · Melrose Park, IL
Key facts
| Inspection ID | 1311592 |
|---|---|
| Firm | Fresenius Kabi USA LLC |
| FEI number | 1450022 |
| Address | 2085 N Hawthorne Ave |
| City | Melrose Park |
| State | IL |
| ZIP | 60160 |
| Fiscal year | 2026 |
| Inspection end date | Feb 18, 2026 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 733107 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data